+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fungal Keratitis Treatment Market 2023-2027

  • PDF Icon

    Report

  • 162 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5892890
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The fungal keratitis treatment market is forecasted to grow by USD 189.44 million during 2022-2027, accelerating at a CAGR of 4.39% during the forecast period. The report on the fungal keratitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness about eye diseases, presence of online sites selling fungal keratitis treatment drugs, and increasing innovation of ocular novel drug delivery systems.

The fungal keratitis treatment market is segmented as below:

By Route Of Administration

  • Oral
  • Injection
  • Topical

By Distribution Channel

  • Hospitals
  • Drug stores
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in funding for research on ophthalmic diseases as one of the prime reasons driving the fungal keratitis treatment market growth during the next few years. Also, emerging new targets for treatment of fungal keratitis and rising demand for non-invasive fungal keratitis tests will lead to sizable demand in the market.

The report on the fungal keratitis treatment market covers the following areas:

  • Fungal keratitis treatment market sizing
  • Fungal keratitis treatment market forecast
  • Fungal keratitis treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fungal keratitis treatment market vendors that include A.S. Lifesciences, Alvogen Iceland ehf, Aravind Eye Care System, Astellas Pharma Inc., Bayer AG, Cipla Ltd., Gilead Sciences Inc., Glenmark Pharmaceuticals Ltd., Goldfield Healthcare, Grevis Pharmaceuticals Pvt. Ltd., ISKON REMEDIES and GMT, Merck and Co. Inc., Novartis AG, Novo Holdings AS, Omicron Pharma, Pfizer Inc., Santen Pharmaceutical Co. Ltd., Taj Pharmaceutical Ltd., Viatris Inc., and Wellona Pharma. Also, the fungal keratitis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global fungal keratitis treatment market 2017 - 2021
Exhibit 18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Injection - Market size and forecast 2022-2027
Exhibit 38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Injection - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
6.5 Topical - Market size and forecast 2022-2027
Exhibit 42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ million)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Drug stores - Market size and forecast 2022-2027
Exhibit 56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Alvogen Iceland ehf
Exhibit 115: Alvogen Iceland ehf - Overview
Exhibit 116: Alvogen Iceland ehf - Product/Service
Exhibit 117: Alvogen Iceland ehf - Key offerings
12.4 Aravind Eye Care System
Exhibit 118: Aravind Eye Care System - Overview
Exhibit 119: Aravind Eye Care System - Product/Service
Exhibit 120: Aravind Eye Care System - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 121: Astellas Pharma Inc. - Overview
Exhibit 122: Astellas Pharma Inc. - Product/Service
Exhibit 123: Astellas Pharma Inc. - Key news
Exhibit 124: Astellas Pharma Inc. - Key offerings
12.6 Bayer AG
Exhibit 125: Bayer AG - Overview
Exhibit 126: Bayer AG - Business segments
Exhibit 127: Bayer AG - Key news
Exhibit 128: Bayer AG - Key offerings
Exhibit 129: Bayer AG - Segment focus
12.7 Cipla Ltd.
Exhibit 130: Cipla Ltd. - Overview
Exhibit 131: Cipla Ltd. - Business segments
Exhibit 132: Cipla Ltd. - Key news
Exhibit 133: Cipla Ltd. - Key offerings
Exhibit 134: Cipla Ltd. - Segment focus
12.8 Gilead Sciences Inc.
Exhibit 135: Gilead Sciences Inc. - Overview
Exhibit 136: Gilead Sciences Inc. - Product/Service
Exhibit 137: Gilead Sciences Inc. - Key news
Exhibit 138: Gilead Sciences Inc. - Key offerings
12.9 Glenmark Pharmaceuticals Ltd.
Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
12.10 ISKON REMEDIES and GMT
Exhibit 142: ISKON REMEDIES and GMT - Overview
Exhibit 143: ISKON REMEDIES and GMT - Product/Service
Exhibit 144: ISKON REMEDIES and GMT - Key offerings
12.11 Merck and Co. Inc.
Exhibit 145: Merck and Co. Inc. - Overview
Exhibit 146: Merck and Co. Inc. - Business segments
Exhibit 147: Merck and Co. Inc. - Key news
Exhibit 148: Merck and Co. Inc. - Key offerings
Exhibit 149: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 150: Novartis AG - Overview
Exhibit 151: Novartis AG - Business segments
Exhibit 152: Novartis AG - Key offerings
Exhibit 153: Novartis AG - Segment focus
12.13 Novo Holdings AS
Exhibit 154: Novo Holdings AS - Overview
Exhibit 155: Novo Holdings AS - Product/Service
Exhibit 156: Novo Holdings AS - Key news
Exhibit 157: Novo Holdings AS - Key offerings
12.14 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product/Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.15 Santen Pharmaceutical Co. Ltd.
Exhibit 162: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 163: Santen Pharmaceutical Co. Ltd. - Product/Service
Exhibit 164: Santen Pharmaceutical Co. Ltd. - Key offerings
12.16 Viatris Inc.
Exhibit 165: Viatris Inc. - Overview
Exhibit 166: Viatris Inc. - Business segments
Exhibit 167: Viatris Inc. - Key news
Exhibit 168: Viatris Inc. - Key offerings
Exhibit 169: Viatris Inc. - Segment focus
12.17 Wellona Pharma
Exhibit 170: Wellona Pharma - Overview
Exhibit 171: Wellona Pharma - Product/Service
Exhibit 172: Wellona Pharma - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary €“ Chart on Market Overview
Exhibits 2: Executive Summary €“ Data Table on Market Overview
Exhibits 3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits 4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary €“ Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary €“ Chart on Incremental Growth
Exhibits 8: Executive Summary €“ Data Table on Incremental Growth
Exhibits 9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Injection - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Route of Administration ($ million)
Exhibits 47: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Distribution Channel
Exhibits 51: Data Table on Comparison by Distribution Channel
Exhibits 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Distribution Channel ($ million)
Exhibits 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Alvogen Iceland ehf - Overview
Exhibits 116: Alvogen Iceland ehf - Product/Service
Exhibits 117: Alvogen Iceland ehf - Key offerings
Exhibits 118: Aravind Eye Care System - Overview
Exhibits 119: Aravind Eye Care System - Product/Service
Exhibits 120: Aravind Eye Care System - Key offerings
Exhibits 121: Astellas Pharma Inc. - Overview
Exhibits 122: Astellas Pharma Inc. - Product/Service
Exhibits 123: Astellas Pharma Inc. - Key news
Exhibits 124: Astellas Pharma Inc. - Key offerings
Exhibits 125: Bayer AG - Overview
Exhibits 126: Bayer AG - Business segments
Exhibits 127: Bayer AG - Key news
Exhibits 128: Bayer AG - Key offerings
Exhibits 129: Bayer AG - Segment focus
Exhibits 130: Cipla Ltd. - Overview
Exhibits 131: Cipla Ltd. - Business segments
Exhibits 132: Cipla Ltd. - Key news
Exhibits 133: Cipla Ltd. - Key offerings
Exhibits 134: Cipla Ltd. - Segment focus
Exhibits 135: Gilead Sciences Inc. - Overview
Exhibits 136: Gilead Sciences Inc. - Product/Service
Exhibits 137: Gilead Sciences Inc. - Key news
Exhibits 138: Gilead Sciences Inc. - Key offerings
Exhibits 139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 140: Glenmark Pharmaceuticals Ltd. - Product/Service
Exhibits 141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 142: ISKON REMEDIES and GMT - Overview
Exhibits 143: ISKON REMEDIES and GMT - Product/Service
Exhibits 144: ISKON REMEDIES and GMT - Key offerings
Exhibits 145: Merck and Co. Inc. - Overview
Exhibits 146: Merck and Co. Inc. - Business segments
Exhibits 147: Merck and Co. Inc. - Key news
Exhibits 148: Merck and Co. Inc. - Key offerings
Exhibits 149: Merck and Co. Inc. - Segment focus
Exhibits 150: Novartis AG - Overview
Exhibits 151: Novartis AG - Business segments
Exhibits 152: Novartis AG - Key offerings
Exhibits 153: Novartis AG - Segment focus
Exhibits 154: Novo Holdings AS - Overview
Exhibits 155: Novo Holdings AS - Product/Service
Exhibits 156: Novo Holdings AS - Key news
Exhibits 157: Novo Holdings AS - Key offerings
Exhibits 158: Pfizer Inc. - Overview
Exhibits 159: Pfizer Inc. - Product/Service
Exhibits 160: Pfizer Inc. - Key news
Exhibits 161: Pfizer Inc. - Key offerings
Exhibits 162: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits 163: Santen Pharmaceutical Co. Ltd. - Product/Service
Exhibits 164: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits 165: Viatris Inc. - Overview
Exhibits 166: Viatris Inc. - Business segments
Exhibits 167: Viatris Inc. - Key news
Exhibits 168: Viatris Inc. - Key offerings
Exhibits 169: Viatris Inc. - Segment focus
Exhibits 170: Wellona Pharma - Overview
Exhibits 171: Wellona Pharma - Product/Service
Exhibits 172: Wellona Pharma - Key offerings
Exhibits 173: Inclusions checklist
Exhibits 174: Exclusions checklist
Exhibits 175: Currency conversion rates for US$
Exhibits 176: Research methodology
Exhibits 177: Validation techniques employed for market sizing
Exhibits 178: Information sources
Exhibits 179: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global fungal keratitis treatment market: A.S. Lifesciences, Alvogen Iceland ehf, Aravind Eye Care System, Astellas Pharma Inc., Bayer AG, Cipla Ltd., Gilead Sciences Inc., Glenmark Pharmaceuticals Ltd., Goldfield Healthcare, Grevis Pharmaceuticals Pvt. Ltd., ISKON REMEDIES and GMT, Merck and Co. Inc., Novartis AG, Novo Holdings AS, Omicron Pharma, Pfizer Inc., Santen Pharmaceutical Co. Ltd., Taj Pharmaceutical Ltd., Viatris Inc., and Wellona Pharma.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increase in funding for research on ophthalmic diseases.'

According to the report, one of the major drivers for this market is the growing awareness about eye diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A.S. Lifesciences
  • Alvogen Iceland ehf
  • Aravind Eye Care System
  • Astellas Pharma Inc.
  • Bayer AG
  • Cipla Ltd.
  • Gilead Sciences Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Goldfield Healthcare
  • Grevis Pharmaceuticals Pvt. Ltd.
  • ISKON REMEDIES and GMT
  • Merck and Co. Inc.
  • Novartis AG
  • Novo Holdings AS
  • Omicron Pharma
  • Pfizer Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Taj Pharmaceutical Ltd.
  • Viatris Inc.
  • Wellona Pharma

Related Topics

Related Reports

Global Fungal Keratitis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Fungal Keratitis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 119 Pages
  • Global
From
Global Fungal Keratitis Treatment Market by Route of Administration (Injection, Oral, Topical), Distribution Channel (Drug Stores, Hospitals) - Forecast 2024-2030 - Product Image

Global Fungal Keratitis Treatment Market by Route of Administration (Injection, Oral, Topical), Distribution Channel (Drug Stores, Hospitals) - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Fungal Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Fungal Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Dry Eye Syndrome Drugs Market 2023-2027 - Product Image

Global Dry Eye Syndrome Drugs Market 2023-2027

  • Report
  • 161 Pages
  • Global
From
Global Low-Concentration Atropine Market 2024-2028 - Product Image

Global Low-Concentration Atropine Market 2024-2028

  • Report
  • 155 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.